Intel, OHSU partner to battle cancer in a more personalized, efficient way

Along with the Knight Cancer Institute at Oregon Health & Science University (OSHU), Intel has launched Collaborative Cancer Cloud (CCC), a service designed to enable providers and researchers to securely share genomic, imaging and clinical data among patients.

The collaborative plans, by 2020, to have physicians be able to give a patient a diagnosis and generate a specific treatment plan within 24 hours. Over time, the platform will be modified to support other types of research and treatment, according to a release.

CCC has conducted initial technical connecting of servers with OHSU as well as two other unidentified facilities in Austin and Boston.

The collaborative cloud "ties together top cancer institutions across the world to share data and advance scientific discovery. The cloud provides access to technology and services (analytics platforms and tools) that dramatically increase the speed, precision and cost-effectiveness of analyzing a patient's individual genetic profile. New big data technologies across a number of Intel's ecosystem partners are making this vision a reality in a way that can become mainstream across large numbers of hospitals and research institutions," according to information on Intel's website.

General availability of the Collaborative Cancer Cloud is expected in the first quarter of 2016 with no cost to join other than an organization’s costs for putting the infrastructure in place.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup